CoChat

Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy

Open access
Hirukawa, Alison, Singh, Salendra, Wang, Jarey, Rennhack, Jonathan P., Swiatnicki, Matthew, Sanguin-Gendreau, Virginie, Zuo, Dongmei, Daldoul, Kamilia, Lavoie, Cynthia, Park, Morag, Andrechek, Eran R., Westbrook, Thomas F., Harris, Lyndsay N., Varadan, Vinay, Smith, Harvey W., Muller, William J. · 2019 · Cell Reports
Cited by 41

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Monoclonal antibodies (mAbs) targeting the oncogenic receptor tyrosine kinase ERBB2/HER2, such as Trastuzumab, are the standard of care therapy for breast cancers driven by ERBB2 overexpression and activation. However, a substantial proportion of patients exhibit de novo resistance. Here, by comparing matched Trastuzumab-naive and post-treatment patient samples from a neoadjuvant trial, we link resistance with elevation of H3K27me 3 , a repressive histone modification catalyzed by polycomb repressor complex 2 (PRC2). In ErbB2+ breast cancer models, PRC2 silences endogenous retroviruses (ERVs) to suppress anti-tumor type-I interferon (IFN) responses. In patients, elevated H3K27me 3 in tumor cells following Trastuzumab treatment correlates with suppression of interferon-driven viral defense gene expression signatures and poor response. Using an immunocompetent model, we provide evidence that EZH2 inhibitors promote interferon-driven immune responses that enhance the efficacy of anti-ErbB2 mAbs, suggesting the potential clinical benefit of epigenomic reprogramming by H3K27me 3 depletion in Trastuzumab-resistant disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.08.105

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Hirukawa, A., Singh, S., Wang, J., Rennhack, J. P., Swiatnicki, M., Sanguin-Gendreau, V., Zuo, D., Daldoul, K., Lavoie, C., Park, M., Andrechek, E. R., Westbrook, T. F., Harris, L. N., Varadan, V., Smith, H. W., & Muller, W. J.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-10
Volume
29
Issue
2
Pages
249-257.e8
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2979604098
Cited by
41
References
10
FWCI
1.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.